DIVISION OF CARDIOLOGY - SUMMARY OF WEEKLY ROUNDS SCHEDULE MONDAY, MARCH 14 to FRIDAY, MARCH 18, 2016

Monday, March 14: 8:00-9:00 Cardiovascular Grand Rounds – No Rounds – March Break 12:00- B6-115 UH Adult Congenital Cardiac Surgery Rounds - Videoconference from 1:30 Toronto OTN Event Cases & Learning Objectives: # Case 1 – Dr. Roche Dx: Unrepaired cyanotic congenital heart defect. Original anatomy Taussig-Bing DORV with subpulmonic VSD – ASD-PS. Surgical right-sided BT shunt in 1980. Central shunt in 2005. Pulmonary hypertension 50897392 on tadalafil. To review cath, echo and MRI. Management planning. Case 2 – Dr. Osten Dx: Anomalous pulmonary vein drainage and sinus venosus defect. Asymptomatic. To review cath, echo and MRI. Surgical referral. Case 3 – Dr. Roche Dx: Secundum ASD, S/T repaired in 1995. Severe pulmonary insufficiency with mildly dilated right ventricle. Atrial flutter – cardioverted in 2015. To review cath, echo, MRI and CP study. Management planning. Case 4 – Dr. Wald Dx: DORV with tunnel repair & VSD closure. Severe aortic regurgitation-symptomatic. To review cath, echo, MRI, CT scan and CP study. Surgical referral. Case 5 – Dr. Oechslin Dx: Tricupsid atresia + dTGA, DKS. Anastomosis then lateral tunnel. Fontan. A Fib + service MR. To review cath, echo and MRI. Surgical referral. Case 6 – Dr. Oechslin Dx: Marfan syndrome with prior endocarditis & aortic root + bioprosthetic AVR/MVR. Severe bioprosthetic AS with decreased EF. To review cath, echo, MRI and EST. Surgical referral.

Tuesday, March 15: 7:00-8:00 B6-115 UH Complex Revascularization Rounds Presenters: CV Surgeons & Interventional Cardiologists No Rounds – March Break 2:00-5:00 B6-128 UH DIDACTIC EDUCATION SESSIONS – No sessions – March Break

Wednesday, March 16: 8:00-9:00 B6-115 UH EP Rounds: Device Rounds Presenters: Attendings & Fellows Learning Objectives: OTN Event 1. To develop a systematic approach to device tracings. # 2. To discuss interesting case examples. 50203308 3. To review programming features and troubleshooting. 12:00- B6-115 UH Adult Congenital Cardiac Teaching Rounds - Videoconference from 1:00 & Toronto C2-504 VH No Rounds – March Break

Thursday, March 17: 8:00-9:00 B6-128 UH Graphics Rounds – No Rounds – March Break Electrophysiology Journal Club Attendance open to Electrophysiologists 6:30 pm 583 Eclipse and EP Fellows, Residents and EP Research Staff. RSVP to Charlene Grass Walk, London (Ext. 33830 or email [email protected]) Topic: Phrenic nerve injury with cryoballoon catheter ablation for AF Papers to be reviewed: 1. K. Ballut/K. Sidhu: Comparison between radiofrequency with contact force-sensing and second- generation cryoballoon for paroxysmal atrial fibrillation catheter ablation: a multicenter European evaluation F. Squara et al. Europace (2015) 17, 718-724 2. A. Kazemi Saeid: Phrenic nerve paralysis during cryoballoon ablation for atrial fibrillation: A Comparison between the first- and second-generation balloon R. Casado-Arroyo et al. Heart Rhythm 2013;10:1318-1324. 3. T. Nguyen: Anatomic predictors of phrenic nerve injury in the setting of pulmonary vein isolation using the 28-mm second-generation cryoballoon E. Stroker, et al. Heart Rhythm 2016;13:342-351. 4. K. Ng: Effect of cryoballoon inflation at the right superior pulmonary vein orifice on phrenic nerve location K. Iso et al. Heart Rhythm 2016;13:28-36 & Fluroscopic position of the second-generation cryoballoon during ablation in the right superior pulmonary vein as a predictor of phrenic nerve injury Y Saitoh et al. Europace 2015Nov26. Pii: euv362 [Epub ahead of print] Learning Objectives: 1. To systematically appraise and assimilate scientific evidence from journal articles and how it can be applied to clinical practice and improvement in patient care. 2. To stay up to date with advances in biomedical and clinical evidence and to facilitate self-learning and professional development. 3. To provide a forum for discussion and peer-review between health care professionals on current best practice that is evidence based.

Friday, March 18: 8:00-9:00 B6-128 UH EP Tracing Rounds: Case Presentations with ECG and Intra-cardiac tracings Presenters: Attendings & Fellows Learning Objectives: 1. To develop a systematic approach to EP tracings. 2. To discuss interesting case examples. 3. To review electrophysiology principles and concepts.

Some of these educational activities/rounds are an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada, approved by the Division of Cardiology Education Committee - Western University.

Supported by unrestricted grants-in-aid provided by: Aegerion Pharmaceuticals (Juxtapid (lomitapide)), Amgen Canada Inc. (Repatha), AstraZeneca Canada Inc. (Brilinta (Ticagrelor)), Bayer HealthCare Pharmaceuticals (XARELTO® rivaroxaban tablet), Boehringer Ingelheim (Canada) Ltd. (Pradax (dabigatran), Twynsta (telmisartan/amlodipine)), Bristol-Myers Squibb Canada & Pfizer Canada Inc., (Eliquis (apixaban)), Medtronic of Canada Inc., Merck (Ezetrol, Olmetec®), Novartis Pharmaceuticals of Canada Inc. (Entresto), Servier Canada Inc. (Coversyl)